These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 35869623)
21. Intraoperative anaphylaxis to sugammadex and a protocol for intradermal skin testing. Sadleir PH; Russell T; Clarke RC; Maycock E; Platt PR Anaesth Intensive Care; 2014 Jan; 42(1):93-6. PubMed ID: 24471669 [TBL] [Abstract][Full Text] [Related]
22. Sugammadex for reversal of neuromuscular blockade in pediatric patients: Results from a phase IV randomized study. Voss T; Wang A; DeAngelis M; Speek M; Saldien V; Hammer GB; Wrishko R; Herring WJ Paediatr Anaesth; 2022 Mar; 32(3):436-445. PubMed ID: 34878707 [TBL] [Abstract][Full Text] [Related]
23. Rocuronium: high risk for anaphylaxis? Rose M; Fisher M Br J Anaesth; 2001 May; 86(5):678-82. PubMed ID: 11575345 [TBL] [Abstract][Full Text] [Related]
24. Rocuronium-induced respiratory paralysis refractory to sugammadex in Charcot-Marie-Tooth disease. Hiramatsu S; Moriwaki K; Nakao M; Tsutsumi YM Can J Anaesth; 2022 Mar; 69(3):364-368. PubMed ID: 34902106 [TBL] [Abstract][Full Text] [Related]
25. Rapid arousal from anaesthesia after reversal of deep rocuronium-induced neuromuscular block with sugammadex in a neuroradiological procedure. Giuffrida M; Ledingham NS; Machi P; Czarnetzki CA BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34417232 [TBL] [Abstract][Full Text] [Related]
26. [Fast recovery of haemodynamic and ventilatory functions after sugammadex bolus following rocuronium-induced anaphylactic shock refractory to conventional treatment]. Raft J; Leclercq M; Longrois D; Meistelman C Ann Fr Anesth Reanim; 2012 Feb; 31(2):158-61. PubMed ID: 22197044 [TBL] [Abstract][Full Text] [Related]
27. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine. Sacan O; White PF; Tufanogullari B; Klein K Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210 [TBL] [Abstract][Full Text] [Related]
28. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia. Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538 [TBL] [Abstract][Full Text] [Related]
29. Sugammadex: a cyclodextrin to reverse neuromuscular blockade in anaesthesia. Donati F Expert Opin Pharmacother; 2008 Jun; 9(8):1375-86. PubMed ID: 18473711 [TBL] [Abstract][Full Text] [Related]
31. Rocuronium-induced neuromuscular block and sugammadex in pediatric patient with duchenne muscular dystrophy: A case Report. Kim JE; Chun HR Medicine (Baltimore); 2017 Mar; 96(13):e6456. PubMed ID: 28353578 [TBL] [Abstract][Full Text] [Related]
32. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block. Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472 [TBL] [Abstract][Full Text] [Related]
33. Residual paralysis caused by 50 mg rocuronium after reversal with 4 mg/kg sugammadex: a case report. Uzawa K; Seki H; Yorozu T BMC Anesthesiol; 2021 May; 21(1):154. PubMed ID: 34016059 [TBL] [Abstract][Full Text] [Related]
34. Two Cases of Rocuronium-Induced Anaphylaxis/Anaphylactic Shock Successfully Treated With Sugammadex. Hashimoto M; Sato Boku A; Tachi N; Okumura Y; Kadoi K; Harada J; Okuda M Anesth Prog; 2019; 66(3):151-155. PubMed ID: 31545668 [TBL] [Abstract][Full Text] [Related]
35. A new approach to anesthesia management in myasthenia gravis: reversal of neuromuscular blockade by sugammadex. de Boer HD; van Egmond J; Driessen JJ; Booij LH Rev Esp Anestesiol Reanim; 2010 Mar; 57(3):181-4. PubMed ID: 20422852 [TBL] [Abstract][Full Text] [Related]
36. The Myth of Rescue Reversal in "Can't Intubate, Can't Ventilate" Scenarios. Naguib M; Brewer L; LaPierre C; Kopman AF; Johnson KB Anesth Analg; 2016 Jul; 123(1):82-92. PubMed ID: 27140684 [TBL] [Abstract][Full Text] [Related]
37. Does the pretreatment of magnesium sulphate affect the sugammadex reversal time for rocuronium-induced neuromuscular blockade? A meta-analysis. Miao M; Zhang J J Clin Anesth; 2020 Mar; 60():78-79. PubMed ID: 31476625 [No Abstract] [Full Text] [Related]
38. Reversal of profound rocuronium neuromuscular blockade by sugammadex in anesthetized rhesus monkeys. de Boer HD; van Egmond J; van de Pol F; Bom A; Booij LH Anesthesiology; 2006 Apr; 104(4):718-23. PubMed ID: 16571967 [TBL] [Abstract][Full Text] [Related]
39. Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment. Chambers D; Paulden M; Paton F; Heirs M; Duffy S; Craig D; Hunter J; Wilson J; Sculpher M; Woolacott N Health Technol Assess; 2010 Jul; 14(39):1-211. PubMed ID: 20688009 [TBL] [Abstract][Full Text] [Related]
40. Reversal of profound and "deep" residual rocuronium-induced neuromuscular blockade by sugammadex: a neurophysiological study. Pavoni V; Gianesello L; De Scisciolo G; Provvedi E; Horton D; Barbagli R; Conti P; Conti R; Giunta F Minerva Anestesiol; 2012 May; 78(5):542-9. PubMed ID: 22298182 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]